Market Research Logo

Global Bone Graft and Substitute Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

Global Bone Graft and Substitute Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 – 2023

The global bone graft and substitutes market is anticipated to grow at a CAGR of 4.7% during 2016 to 2023Bones have the usual capability to rebuild, but the surgical intervention is required to regenerate the bone if the defects exceed a critical size. The healing of fractures is a physiological process that fallouts in bone union. It is estimated that 5 to 10% of all fractures are related with reduced healing. Hereafter, currently, numerous bone grafts and substitutes are offered to redevelop the bone. According to the American Academy of Orthopaedic Surgeons, the ideal BGS (bone graft substitute) is easy to use, biocompatible, osteoconductive, osteoinductive, looks like bone, and are cost effective. The major factors which are driving the bone graft and substitute market are rising incidences of musculoskeletal conditions due to sudden exertion and repetitive strain, increasing base of elderly population, development of biocompatible synthetic bone grafts which is used for sinus lift procedure. The major restraints of the bone grafts and substitutes market are high cost of surgeries, and the stringent regulatory approval process.

The global bone grafts and substitutes market is segmented into its type and application. The type segment of bone grafts and substitutes market is sub segmented into allografts, bone graft substitutes. The application segment of the bone grafts and substitutes market is further divided into spinal fusion, long bone, foot and ankle, craniomaxilofacial, joint reconstruction, dental. Constant efforts to develop enhanced allografts for example demineralized bone matrix grafts with greater osteoinductive and osteoconductive abilities are expected to have a constructive impact on the development of the market during the forecast period.

Based on geography, the global bone grafts and substitutes market is segmented into North America, Europe, Asia-Pacific and Row. North America was anticipated to be the leading market for bone grafts and substitutes in the year 2016. North America was chiefly accredited to high awareness concerning commercially available products and the availability of advanced infrastructure and greater healthcare expenditure. According to Peter G. Peterson Foundation, the United States per capita healthcare spending is estimated to be $9024 which is more than twice the average as compare to the other developed countries. The major players of the bone grafts and substitutes market are Allosource, Baxter International, Depuy Synthes, Integra Lifesciences Holdings Corporation, Johnson & Johnson, Medtronic Plc, Musculoskeletal Transplant Foundation, Nuvasive, Inc, Orthofix Holdings, Inc, Orthovita, Inc, Stryker Corporation, Smith & Nephew, Inc, Wright Medical Group N.V, Xtant Medical Holdings, Inc, Zimmer Biomet Holdings, Inc. Acquisition, merger, innovation and new product launch are the major strategies which help to sustain in the market. On December 19, 2016 Kuros Biosciences is acquire Xpand Biotechnology, the collective entity expects to feat two complementary technologies Kuros’s fibrin/PTH biologics platform and Xpand’s synthetic surface science technology. This acquisition is Form Orthobiologics Firm with Bone Graft Substitute.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
2. MARKET OVERVIEW
2.1. GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION AND SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. PRICING ANALYSIS
2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES AND ANALYSIS
2.8.2. MARKET SHARE
2.8.3. TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
3. MARKET DETERMINANTS
3.1. MARKET DRIVERS
3.1.1. RISING INCIDENCES OF MUSCULOSKELETAL CONDITIONS
3.1.2. INCREASING BASE OF ELDERLY POPULATION
3.1.3. DEVELOPMENT OF BIOCOMPATIBLE SYNTHETIC BONE GRAFTS
3.1.4. TECHNOLOGICAL ADVANCEMENTS
3.1.5. OBESITY AND DIABETES INCREASE THE RISK OF DEGENERATIVE JOINT DISEASES
3.2. MARKET RESTRAINTS
3.2.1. HIGH COST OF SURGERIES
3.2.2. ETHICAL ISSUES ASSOCIATED WITH BONE GRAFTING PROCEDURES.
3.2.3. THE STRINGENT REGULATORY APPROVAL PROCESS.
3.3. MARKET OPPORTUNITIES
3.3.1. RISE IN CLOUD RELATED TECHNOLOGY SPENDING AND DATA CENTER
3.3.2. INCREASING TREND OF CUSTOMIZED RACKS
3.4. MARKET CHALLENGES
3.4.1. RISK RELATED WITH IMMUNE RESPONSE
3.4.2. RISK WITH DISEASE TRANSMISSION
4. MARKET SEGMENTATION
4.1. GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY TYPE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION
4.1.5.1. GLOBAL ALLOGRAFTS MARKET
4.1.5.1.1. APPLICATIONS
4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.5. KEY CONCLUSIONS
4.1.5.2. GLOBAL BONE GRAFT SUBSTITUTES MARKET
4.1.5.2.1. APPLICATIONS
4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5. KEY CONCLUSIONS
4.2. GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY APPLICATION
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION
4.2.5.1. GLOBAL SPINAL FUSION MARKET
4.2.5.1.1. APPLICATIONS
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL LONG BONE MARKET
4.2.5.2.1. APPLICATIONS
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL FOOT AND ANKLE MARKET
4.2.5.3.1. APPLICATIONS
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.2.5.4. GLOBAL CRANIOMAXILOFACIAL MARKET
4.2.5.4.1. APPLICATIONS
4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.4.5. KEY CONCLUSIONS
4.2.5.5. GLOBAL JOINT RECONSTRUCTION MARKET
4.2.5.5.1. APPLICATIONS
4.2.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.5.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.5.5. KEY CONCLUSIONS
4.2.5.6. GLOBAL DENTAL MARKET
4.2.5.6.1. APPLICATIONS
4.2.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.6.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.6.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.6.5. KEY CONCLUSIONS
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
5.2. TOP 10 COMPANY ANALYSIS
6. GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY REGION
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GEOGRAPHIC SEGMENTATION
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY APPLICATION ANALYSIS
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S.
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) ($ MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. ITALY
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.2.2.6. REST OF EUROPE
6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.2.2.6.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.6.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. SOUTH KOREA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. AUSTRALIA
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.3.2.6. REST OF ASIA PACIFIC
6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.3.2.6.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.6.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
7. COMPANY PROFILES
7.1. ALLOSOURCE
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION
7.1.4. STRATEGIC INITIATIVES
7.1.5. SCOT ANALYSIS
7.2. BAXTER INTERNATIONAL
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION
7.2.4. STRATEGIC INITIATIVES
7.2.5. SCOT ANALYSIS
7.3. DEPUY SYNTHES
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION
7.3.4. STRATEGIC INITIATIVES
7.3.5. SCOT ANALYSIS
7.4. INTEGRA LIFESCIENCES HOLDINGS CORPORATION
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION
7.4.4. STRATEGIC INITIATIVES
7.4.5. SCOT ANALYSIS
7.5. JOHNSON & JOHNSON
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION
7.5.4. STRATEGIC INITIATIVES
7.5.5. SCOT ANALYSIS
7.6. MEDTRONIC PLC
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION
7.6.4. STRATEGIC INITIATIVES
7.6.5. SCOT ANALYSIS
7.7. MUSCULOSKELETAL TRANSPLANT FOUNDATION
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION
7.7.4. STRATEGIC INITIATIVES
7.7.5. SCOT ANALYSIS
7.8. NUVASIVE, INC.
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION
7.8.4. STRATEGIC INITIATIVES
7.8.5. SCOT ANALYSIS
7.9. ORTHOFIX HOLDINGS, INC
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION
7.9.4. STRATEGIC INITIATIVES
7.9.5. SCOT ANALYSIS
7.10. ORTHOVITA, INC
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION
7.10.4. STRATEGIC INITIATIVES
7.10.5. SCOT ANALYSIS
7.11. STRYKER CORPORATION
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION
7.11.4. STRATEGIC INITIATIVES
7.11.5. SCOT ANALYSIS
7.12. SMITH & NEPHEW, INC.
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION
7.12.4. STRATEGIC INITIATIVES
7.12.5. SCOT ANALYSIS
7.13. WRIGHT MEDICAL GROUP N.V.
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION
7.13.4. STRATEGIC INITIATIVES
7.13.5. SCOT ANALYSIS
7.14. XTANT MEDICAL HOLDINGS, INC
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION
7.14.4. STRATEGIC INITIATIVES
7.14.5. SCOT ANALYSIS
7.15. ZIMMER BIOMET HOLDINGS, INC.
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION
7.15.4. STRATEGIC INITIATIVES
7.15.5. SCOT ANALYSIS
LIST OF TABLES
GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY TYPE $ MILLION)
GLOBAL ALLOGRAFTS BY GEOGRAPHY ($ MILLION)
GLOBAL BONE GRAFT SUBSTITUTES BY GEOGRAPHY ($ MILLION)
GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY APPLICATION ($ MILLION)
GLOBAL SPINAL FUSION BY GEOGRAPHY ($ MILLION)
GLOBAL LONG BONE BY GEOGRAPHY ($ MILLION)
GLOBAL FOOT AND ANKLE BY GEOGRAPHY ($ MILLION)
GLOBAL CRANIOMAXILOFACIAL BY GEOGRAPHY ($ MILLION)
GLOBAL JOINT RECONSTRUCTION BY GEOGRAPHY ($ MILLION)
GLOBAL DENTAL BY GEOGRAPHY ($ MILLION)
NORTH AMERICA DATA CENTER RACK SERVER MARKET ($ MILLION)
EUROPE DATA CENTER RACK SERVER MARKET ($ MILLION)
ASIA PACIFIC DATA CENTER RACK SERVER MARKET ($ MILLION)
REST OF THE WORLD DATA CENTER RACK SERVER MARKET ($ MILLION)
LIST OF FIGURES
GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY ALLOGRAFTS ($ MILLION)
GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY BONE GRAFT SUBSTITUTES ($ MILLION)
GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY SPINAL FUSION ($ MILLION)
GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY LONG BONE ($ MILLION)
GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY FOOT AND ANKLE ($ MILLION)
GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY CRANIOMAXILOFACIAL ($ MILLION)
GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY JOINT RECONSTRUCTION ($ MILLION)
GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY DENTAL ($ MILLION)
UNITED STATES (U.S.) DATA CENTER RACK SERVER MARKET ($ MILLION)
CANADA DATA CENTER RACK SERVER MARKET ($ MILLION)
UNITED KINGDOM (UK) DATA CENTER RACK SERVER MARKET ($ MILLION)
FRANCE DATA CENTER RACK SERVER MARKET ($ MILLION)
GERMANY DATA CENTER RACK SERVER MARKET ($ MILLION)
SPAIN DATA CENTER RACK SERVER MARKET ($ MILLION)
ITALY DATA CENTER RACK SERVER MARKET ($ MILLION)
ROE DATA CENTER RACK SERVER MARKET ($ MILLION)
INDIA DATA CENTER RACK SERVER MARKET ($ MILLION)
CHINA DATA CENTER RACK SERVER MARKET ($ MILLION)
JAPAN DATA CENTER RACK SERVER MARKET ($ MILLION)
KOREA DATA CENTER RACK SERVER MARKET ($ MILLION)
AUSTRALIA DATA CENTER RACK SERVER MARKET ($ MILLION)
ROW APAC DATA CENTER RACK SERVER MARKET ($ MILLION)
LATIN AMERICA DATA CENTER RACK SERVER MARKET ($ MILLION)
MENA DATA CENTER RACK SERVER MARKET 2014-2023 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report